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Abstract
Depression is a common mental illness and research has focused on late childhood and adolescence in an attempt to prevent or
reduce later psychopathology and/or social impairments. It is important to establish and study population-averaged trajectories
of depressive symptoms across adolescence as this could characterise speciﬁc changes in populations and help identify critical
points to intervene with treatment. Multilevel growth-curve models were used to explore adolescent trajectories of depressive
symptoms in 9301 individuals (57% female) from the Avon Longitudinal Study of Parents and Children, a UK based
pregnancy cohort. Trajectories of depressive symptoms were constructed for males and females using the short mood and
feelings questionnaire over 8 occasions, between 10 and 22 years old. Critical points of development such as age of peak
velocity for depressive symptoms (the age at which depressive symptoms increase most rapidly) and the age of maximum
depressive symptoms were also derived. The results suggested that from similar initial levels of depressive symptoms at age
11, females on average experienced steeper increases in depressive symptoms than males over their teenage and adolescent
years until around the age of 20 when levels of depressive symptoms plateaued and started to decrease for both sexes. Females
on average also had an earlier age of peak velocity of depressive symptoms that occurred at 13.5 years, compared to males
who on average had an age of peak velocity at 16 years old. Evidence was less clear for a difference between the ages of
maximum depressive symptoms which were on average 19.6 years for females and 20.4 for males. Identifying critical periods
for different population subgroups may provide useful knowledge for treating and preventing depression and could be tailored
to be time speciﬁc for certain groups. Possible explanations and recommendations are discussed.
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Introduction
Depression is a common mental illness believed to affect
more than 300 million people worldwide (WHO 2017).
Depression is comorbid with other psychiatric conditions
including anxiety, bipolar disorder and schizophrenia
(Malhi and Mann 2018; Thapar et al. 2012), and is often
associated with increased substance misuse, impaired edu-
cational attainment and increased risk of suicide (Fergusson
et al. 2007; Marmorstein 2009).
One avenue for research has focused on childhood and
adolescent depressive symptoms as a potentially modiﬁable
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risk factor for more severe depression during adulthood
(Hill et al. 2014; Musliner et al. 2016) and previous research
has shown that elevated levels of depressive symptoms
within a population (and even those that never rise above
the threshold for depression) are associated with a greater
risk for depression in later life (Ellis et al. 2017; Yar-
oslavsky et al. 2013). Evidence concludes that the period
between late childhood and adolescence may be important
for subsequent mental health and social functioning, thus
identifying and treating elevated depressive symptoms
during this time could limit or prevent depression in later
life through support and services (Fergusson et al. 2005;
Thapar et al. 2012).
Research has yet to fully understand the nature of tra-
jectories of depressive symptoms across adolescence and
into young adulthood and identifying the key characteristics
and time course of depressive symptoms across this period
will ultimately aid in improving treatments and interven-
tions. The current study attempts to build upon previous
research by estimating trajectories of depressive symptoms
between late childhood and young adulthood, and identi-
fying critical points along those trajectories that could shed
light on the nature of how these trajectories of depressive
symptoms develop and change over time.
Previous studies have examined trajectories of depressive
symptoms between childhood and young adulthood in an
attempt to explore the nature and risk factors underlying
greater depressive symptoms, for reviews see Musliner et al.
(2016), Shore et al. (2018) and Schubert et al. (2017).
Indeed, research suggests that trajectories of depressive
symptoms tend to increase from childhood through ado-
lescence, before decreasing in young adulthood (Ge et al.
2006; Natsuaki et al. 2009). Evidence also suggests that
these trajectories may peak in mid-to-late adolescence,
towards the ages of 15–17 years old (Costello et al. 2008;
Ferro et al. 2015b).
Other research has suggested that depressive symptoms
may increase post adolescence. For instance, Ge et al.
(2001) demonstrated that trajectories of depressive symp-
toms were highest around the ages of 17–18 years old, but
were unable to explore depressive symptoms further than
this age due to a cease in data collection. Other research has
suggested that trajectories of depressive symptoms are
highest in young adulthood (towards age of 20) but then
decline until older age (Sutin et al. 2013). In this instance,
Sutin and colleagues did not have data preceding young
adulthood so they were unable to explore if trajectories were
higher around adolescence. It may be that trajectories of
depressive symptoms could peak outside adolescence, yet
do not have preceding and succeeding data around this
period to substantiate these claims (Brendgen et al. 2005; St
Clair et al. 2012). Likewise, many studies also use small
sample sizes, which can make it difﬁcult to infer about
population level changes of depressive symptoms.
Observing the longitudinal nature of trajectories of
depressive symptoms enables researchers to identify critical
points at which to intervene to limit or prevent more severe
depression. The notion of identifying critical points is not
new (Bartley et al. 1997), but this application to trajectories
of depressive symptoms has yet to be fully explored. Using
depressive symptoms data from childhood to young adult-
hood (12 to 25 years), Ferro et al. (2015b) identiﬁed the age
of maximum depressive symptoms to occur between the
ages of 15 to 17 years old, whilst Rawana and Morgan
(2014) found that depressive symptoms were highest at
approximately 17 years old. Similar results have also been
observed by Natsuaki et al. (2009) who plotted trajectories
that indicated the age of maximum depressive symptoms
was 16 years old. Other research has also found evidence of
sex differences in regards to an age of maximum depressive
symptoms with females reaching this maximum earlier than
males (Adkins et al. 2009; Edwards et al. 2014).
While identifying the age of maximum depressive
symptoms is important for characterising the nature of
depressive symptoms, calculation of the age of peak velo-
city may also be important (i.e., the age at which depressive
symptoms are increasing most rapidly). Research has sug-
gested that identifying depressive symptoms early or before
depression already manifested may be a key step towards
preventing greater depressive symptoms or severe depres-
sion from occurring (Cuijpers and Smit 2004; Kessler et al.
2001). By identifying the age of peak velocity of depressive
symptoms, it may be possible to highlight a critical point
where interventions and treatments could be implemented to
reduce or limit greater depressive symptoms from escalat-
ing. However, no studies have calculated the age of peak
velocity of depressive symptoms and studies that have
previously identiﬁed the age of maximum depressive
symptoms have done so using heuristics, graphs or ﬁgures
rather than empirically calculating these ages.
Trajectories of depressive symptoms are not homo-
geneous within the population (Musliner et al. 2016), and
a number of risk factors can inﬂuence trajectories of
depressive symptoms (Weeks et al. 2014; Yaroslavsky
et al. 2013). Consistent evidence has shown that females
tend to have higher trajectories of depressive symptoms
compared to males (Dekker et al. 2007; Yaroslavsky et al.
2013). Although in several studies where heterogeneous
trajectories are identiﬁed, there is some evidence that
females are associated with more intermediary trajectories
such as “increasing”, “late onset” or “early high” (Cost-
ello et al. 2008; Olino et al. 2010). These studies suggest
there may be mechanisms that underpin membership into
varying trajectories, but the extent to which this can be
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explained has yet to be fully understood. Females also
appear to have a higher peak along these trajectories of
depressive symptoms (Adkins et al. 2009; Ge et al. 2001;
Natsuaki et al. 2009), and may reach this peak earlier than
males (Edwards et al. 2014), yet it is also not clear why
this is the case.
Current Study
Previous research has shown that trajectories of depressive
symptoms tend to increase throughout adolescence and into
young adulthood (Costello et al. 2008; Ferro et al. 2015b),
and that females are more likely to have higher trajectories of
depressive symptoms (Ge et al. 2006; Natsuaki et al. 2009).
However, the longitudinal nature of depressive symptoms has
yet to be fully understood as previous research has used small
sample sizes, not had depressive symptoms data that spans a
wide enough temporal window, and/or has been unable to
measure depressive symptoms over important periods and
transitions of development (e.g., from late childhood to ado-
lescence and/or from adolescence into young adulthood).
Likewise, no studies have identiﬁed critical periods of tra-
jectories of depressive symptoms that could potentially
highlight modiﬁable stages at which to best intervene. Iden-
tifying critical points such as the age of peak velocity of
depressive symptoms (i.e., the age at which depressive
symptoms are increasing most rapidly) could help researchers
and clinicians target a stage of development where depressive
symptoms might be increasing at the fastest rate, which may
in turn prevent or reduce higher symptoms or the onset of
depression. The current study aims to address the previous
limitations ﬁrstly by using multilevel growth-curve modelling
to create trajectories of depressive symptoms in a large UK
based population cohort. Multilevel growth-curve modelling
has previously been a useful method for examining trajec-
tories of depressive symptoms (Ferro et al. 2015a; Rawana
and Morgan 2014). Trajectories are created for both male and
female populations between 10 and 22 years using 8 waves of
depressive symptoms follow up. It was hypothesised that
females would have higher trajectories of depressive symp-
toms throughout adolescence and young adulthood compared
to males. Secondly, the ages of peak velocity and maximum
depressive symptoms, as well as the depressive symptoms
scores at both these ages for males and females are then
calculated and compared. It was also hypothesised that the
ages of peak velocity and maximum depressive symptoms
would be earlier for females given their tendency to have
elevated trajectories at the beginning of adolescence and that
they commence on these trajectories earlier than males.
Methods
Participants
Participants were from the Avon Longitudinal Study of
Parents and Children (ALSPAC), an ongoing population-
based study in the South-West of England designed to
examine the effects of a number of factors on health and
development. ALSPAC recruited pregnant mothers with an
estimated delivery date between April 1991 and December
1992. The initial cohort consisted of 14,541 pregnancies,
with 13,988 children still alive one year later (52% males
and 48% females). ALSPAC children were slightly more
educated at age 16 compared to the national average,
slightly more likely to come from homeowner backgrounds
and slightly more likely to be of Caucasian descent (Boyd
et al. 2013). Ethical oversight for the study was obtained
from the ALSPAC Law and Ethics Committee and Local
Research Ethics Committees. Participant data has been
collected on the mothers, fathers and children from early
pregnancy, and measured via questionnaires and regular
clinic visits. Part of this data was collected using REDCap
(https://projectredcap.org/resources/citations/). Detailed
information about ALSPAC is available on the study
website (www.bris.ac.uk/alspac), which also contains a
fully searchable data dictionary (www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary). See Table 1 for
participant characteristics.
Measures
Depressive symptoms
The main outcome measure was depressive symptoms,
assessed using the short mood and feelings questionnaire
(SMFQ) (Angold et al. 1995). The SMFQ is a 13-item
questionnaire that measures the occurrence of depressive
symptoms over the preceding two weeks with higher scores
indicating more severe depressive symptoms (range 0–26).
The SMFQ correlates highly with clinical measures of
depression (Turner et al. 2014), and has been used in pre-
vious studies examining trajectories of depressive symp-
toms (Kingsbury et al. 2016; Mahedy et al. 2017). Self-
report SMFQ data was used from eight occasions beginning
in late childhood and extending to young adulthood. There
was good reliability for the depressive symptoms scores
used in this sample (α= 0.79–0.91). Questionnaires were
either completed via postal/internet questionnaires or by
computer at a clinic visit. See Table 1 for SMFQ descriptive
and reliability statistics.
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Biological sex
Biological sex was identiﬁed from birth notiﬁcations around
the time of delivery and coded as a dummy variable for
being female (male= 0; female= 1). Participants were
removed from the analysis if sex was unknown. See Table 2
for sex speciﬁc SMFQ descriptive statistics.
Statistical Methods
Trajectories of depressive symptoms were estimated using
multilevel growth-curve modelling (Bryk and Raudenbush
1987; Steele 2008). Descriptive statistics indicated the
change in depressive symptoms followed a non-linear pat-
tern (Table 1). Thus the model needed to appropriately
capture the non-linearity of these trajectories. A multilevel
cubic growth-curve polynomial model was chosen for two
reasons. First, entering age as a cubic polynomial ﬁtted the
data better and produced more plausible results than
entering age as a quadratic or quartic polynomial (see
Supplementary Table 3). Second, compared to more com-
plex cubic splines and fractional polynomials which have
also been used to model non-linear growth in other contexts
(Grajeda et al. 2016; Howe et al. 2016), entering age as a
cubic polynomial led to a more parsimonious model.
Multilevel cubic growth-curve polynomials have been used
in previous studies examining trajectories of depressive
symptoms (Ferro et al. 2015a; Rawana and Morgan 2014).
Model ﬁt was assessed using likelihood ratio tests and
information criteria, consistent with other studies using
multilevel growth-curve models (Rawana and Morgan
2014; Singer and Willett 2003). The preferred model spe-
ciﬁes separate population-averaged trajectories for males
and females by interacting the ﬁxed-effects age polynomial
terms with the female dummy variable. The age polynomial
terms were allowed to vary randomly across individuals to
capture each individual’s unique trajectory. The model can
be written as
yij ¼ β0 þ β1tij þ β2t2ij þ β3t3ij þ β4x1j þ β5x1jtij þ β6x1jt2ij
þ β7x1jt3ij þ u0j þ u1jtij þ u2jt2ij þ u3jt3ij þ eij
ð1Þ
where yij is the depressive symptom score and tij is the age
1
for individual j at occasion i, x1j is a dummy variable for
being female, and u0j, u1j, u2j, and u3j are the random
intercept, linear, quadratic and cubic effects of age,
respectively. The occasion-speciﬁc residual eij allows the
depressive symptom scores to deviate from the individual-
speciﬁc cubic trajectories.
The random effects are assumed multivariate normal
distributed with zero mean vector and constant covariance
matrix
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Table 1 Descriptive statistics
and reliability of the short mood
and feelings questionnaire
(SMFQ)
Occasion Mean age Sample size Mean
SMFQ
SMFQ SD Above SMFQ
threshold (<11)
α Source of SMFQ
1 10.65 7335 4.04 3.51 5.4% 0.797 Clinic
2 12.81 6692 3.97 3.86 7.08% 0.842 Clinic
3 13.84 5996 4.92 4.49 11.64% 0.865 Clinic
4 16.68 4977 5.91 5.64 18.08% 0.908 Questionnaire
5 17.84 4486 6.59 5.25 21.67% 0.897 Clinic
6 18.65 3323 6.83 5.93 21.88% 0.906 Questionnaire
7 21.95 3293 5.7 5.58 18.07% 0.915 Questionnaire
8 22.88 3840 6.21 5.55 18.83% 0.906 Questionnaire
α: Coefﬁcient alpha estimate of reliability for the SMFQ at each occasion. The SMFQ ranges between 0–26
and scores exceeding 11 have been proposed as good markers for depression (see Turner et al. 2014)
Table 2 Descriptive statistics for the short mood and feelings
questionnaire (SMFQ) by sex
Occasion Male
sample
size
Female
sample
size
Mean
male
SMFQ
Male
SMFQ
SD
Mean
female
SMFQ
Female
SMFQ
SD
1 3605 3730 4.17 3.45 3.92 3.91
2 3271 3421 3.57 3.47 4.35 4.16
3 2922 3074 4.09 3.8 5.71 4.93
4 2010 2967 4.31 4.58 7.0 6.02
5 1898 2588 5.63 4.77 7.29 5.47
6 1172 2151 5.34 5.02 7.64 6.21
7 1161 2132 4.87 4.82 6.15 5.90
8 1323 2517 5.35 4.95 6.67 5.79
1 Age was centered to approximately 16 years to make the intercept
more interpretable and is common practise in multilevel growth-curve
modelling studies (Rawana & Morgan, 2014; Singer & Willett, 2003).
To achieve this, the mean age of all the age measurements was cal-
culated and subtracted this from approximately 16 (15.82).
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The elements of the covariance matrix summarise the
degree to which individual-speciﬁc trajectories vary around
the sex-speciﬁc population-averaged trajectories. The resi-
duals are assumed normally distributed with zero mean and
sex speciﬁc variance
eij  N 0; σ2ej
 
where σ2ej ¼ α0 1 x1j
 þ α1x1j ð3Þ
All analyses were conducted using Stata 14 (StataCorp,
College Station, TX, USA) using the user-written runmlwin
command (Leckie and Charlton 2012), which calls the
standalone multilevel modelling package MLwiN v2.35
(www.cmm.bristol.ac.uk/MLwiN/index.shtml). Stata code
is provided in the supplementary materials for reproduci-
bility and extension of this work.
Trajectory features
The population male and female trajectories are therefore
given by
Male : Eðyijjtij; x1j ¼ 0Þ ¼ β0 þ β1tij þ β2t2ij þ β3t3ij
Female : Eðyijjtij; x1j ¼ 1Þ ¼ ðβ0 þ β4Þ þ ðβ1 þ β5Þtij
þðβ2 þ β6Þt2ij þ ðβ3 þ β7Þt3ij
Several features were calculated from these sex-speciﬁc
mean trajectories including: the ages of peak velocity of
depressive symptoms (i.e., ages at which male and female
depressive symptoms are increasing most rapidly), and the
ages of maximum depressive symptoms (i.e., the ages at
which male and female depressive symptoms were the
highest). The depressive symptoms scores were also cal-
culated at each of these critical ages. The delta method in
Stata was used to compare differences in the intercept,
linear, quadratic and cubic terms, as well as at the critical
points between the male and female trajectories. See Sup-
plemental Materials for further details.
Results
There were 9301 individuals with data on sex and at least
one measurement of the SMFQ, resulting in 39,942 mea-
surements (17,362 male [43.47%]/22,580 female
[56.53%]).
Trajectories of Depressive Symptoms
Females and males followed different trajectories (Fig. 1).
The intraclass correlation evaluated at age 16 was 0.56
(SE= 0.01) indicating that over half of the variation in
individuals’ depressive symptoms at this age is captured
by their individual-speciﬁc cubic trajectories. The corre-
lation between the intercept (i.e., ﬁrst measurement of
depressive symptoms) and the slope (i.e., change in
depressive symptoms with every year increase) was 0.52
(SE= 0.03). Table 3 presents the regression coefﬁcients
from the cubic polynomial model. The marginal sex-
speciﬁc trajectories did not differ substantively with the
addition of covariates (see Supplementary materials), so
only the unadjusted trajectories and main features of the
trajectories are described.
The differences in trajectories of depressive symptoms
between males and females are shown in Table 4 and Fig. 2.
Brieﬂy, females had higher trajectories compared to males,
except between 10 and 11 years old where males were
predicted to have higher depressive symptoms. Females
were associated with higher depressive symptoms at 16
years of age (β= 6.7, SE= 0.07 [95% CI: 6.57, 6.83])
compared to males (β= 4.57, SE= 0.07 [95% CI: 4.43,
4.7]; pdiff < 0.001). Females had a higher linear slope (β
= .049, SE= 0.02 [95% CI: 0.45, 0.53]) compared to males
(β= 0.36, SE= 0.02 [95% CI: 0.31, 0.4]; pdiff < 0.001),
which suggested that depressive symptoms increased more
rapidly for females until the age of 20. However, females
had a greater negative quadratic slope (β=−0.04, SE=
0.002 [95% CI: −0.05, −0.03]), implying from around age
20 their depressive symptoms started to decrease, in con-
trast to males (β= 0.01, SE= 0.002 [95% CI: 0.008, 0.2];
pdiff < 0.001). Finally, a negative cubic slope was observed
for both females (β=−0.01, SE= 0.001 [95% CI: −0.001,
−0.004]) and males (β=−0.007, SE= 0.001 [95% CI:
−0.01, −0.006]; pdiff= 0.04), indicating that depressive
symptoms were decreasing from age 20 onwards, however
the current analysis suggested that both sexes decreased at
similar rates into young adulthood (Tables 3 and 4).
Fig. 1 Individual and averaged population trajectories for a random set
of 100 participants. SMFQ short mood and feelings questionnaire
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Age of Peak Velocity and Age at Maximum
Depressive Symptoms
The age of peak velocity in the model was earlier for
females (13.51 years old, SE= 0.32 [95% CI: 12.88,
14.14]) compared to males (16.36 years old, SE= 0.1 [95%
CI: 16.18, 16.55]; pdiff < 0.001). However there was little
evidence of a difference between the age at the maximum
point of depressive symptoms for females (19.61 years old,
SE= 0.5 [95% CI: 18.63, 20.6]) compared to males (20.42
years old, SE= 0.14 [95% CI: 20.14, 20.69]; pdiff= 0.13).
See Table 5 for full statistics.
Depressive Symptoms Score at Age of Peak Velocity
and at Age of Maximum Point of Depressive
Symptoms
The predicted depressive symptoms scores at the estimated
age of peak velocity were higher for females (5.42 points,
SE= 0.06 [95% CI: 5.3, 5.55]) than they were for males
(4.76 points, SE= 0.07 [95% CI: 4.62, 4.91]; pdiff < 0.001).
The depressive symptoms scores at the maximum point of
depressive symptoms were also higher for females (7.7
points, SE= 0.09 [95% CI: 7.52, 7.88]) compared to males
(5.75 points, SE= 0.1 [95% CI: 5.55, 5.95]; pdiff < 0.001).
See Table 5 for full statistics.
Missing Data and Sensitivity Analysis
Missing data were handled using full information maximum
likelihood (FIML), which assumes that data are missing at
random. The initial analysis included individuals with at
least one measurement from the SMFQ. Although indivi-
duals with only one measurement do contribute to the
analysis (e.g. via association between average depressive
symptoms and sex), it is not meaningful to predict and
examine trajectories for these individuals. To overcome
this, a sensitivity analysis was run on a subset of individuals
who had four or more depressive symptom scores. The
sample size reduced from 9,301 to 5,409. However,
removing these individuals had no substantive impact on
the interpretation and conclusions from these trajectories
Table 3 Regression coefﬁcients for the cubic polynomial model
Cubic Polynomial Model (n= 9301)
Parameter Estimate Std. Error p-value
β0—Intercept 4.57 [4.43, 4.7] 0.07 <0.001
β1—Age (slope) 0.37 [0.31, 0.4] 0.027 <0.001
β2—Age
2 (acceleration) 0.01 [0.008, 0.02] 0.002 <0.001
β3—Age
3 (cubic change) −0.007 [−0.009, −0.006] 0.001 <0.001
β4—Female 2.13 [1.95, 2.32] 0.1 <0.001
β5—Female × Age 0.14 [0.06, 0.19] 0.03 <0.001
β6—Female × Age
2 −0.05 [−0.06, −0.05] 0.003 <0.001
β7—Female × Age
3 0.002 [0.0001, 0.003] 0.001 0.04
ICC 0.56
Deviance 227,890.58
95% Conﬁdence intervals given in [parenthesis]
Table 4 Comparing parameter
estimates and trajectories from
the cubic polynomial model
Males Females Difference p-value
Intercept term for SMFQ 4.57 (0.07) 6.7 (0.07) 2.13 (0.1) <0.001
[4.43, 4.7] [6.57, 6.83] [1.95, 2.32]
Linear term for SMFQ 0.36 (0.02) 0.49 (0.02) 0.14 (0.03) <0.001
[0.31, 0.4] [0.45, 0.53] [0.08, 0.19]
Quadratic term for SMFQ 0.01 (0.002) −0.04 (0.002) 0.05 (0.003) <0.001
[0.008, 0.2] [−0.05, −0.03] [0.05, 0.06]
Cubic term for SMFQ −0.007 (0.001) −0.01 (.001) 0.002 (0.001) 0.04
[−0.01, −0.006] [−0.001, −0.004] [0.0001, 0.003]
The intercept was centered to age 16 for interpretability. The differences between each term were calculated
as follows: the intercept term for males (β0) minus the intercept term for females (β0+ β4), the linear term for
males (β1) minus the linear term for females (β1+ β5), the quadratic term for males (β2) minus the quadratic
term for females (β2+β6), the cubic term for males (β3) minus the cubic term for females (β3+β7). Standard
errors are given in (parenthesis), 95% conﬁdence intervals are given in [parenthesis]
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(Supplementary Tables 5 and 8), thus only the full analysis
is reported here. Results were also robust to the inclusion of
covariates that are associated with missing data and attri-
tion. Further analysis on individuals with depressive
symptoms data at ages 10 and 22 revealed varying dis-
tributions of the depressive symptoms data and underlying
demographics compared with individuals who only had
depressive symptoms data at age 10 (i.e., had depressive
symptoms data missing at 22), see Supplementary Table 2.
Further information regarding analyses using these covari-
ates can be found in the Supplementary Materials.
Discussion
The longitudinal nature of trajectories of depressive symp-
toms between adolescence and young adulthood is not fully
established, and research has yet to identify critical periods
of trajectories of depressive symptoms that could potentially
be used to target a stage of development where depressive
symptoms might be increasing at the fastest rate. A greater
understanding of the nature of depressive symptoms would
aid researchers and clinicians in developing and improving
treatments and interventions. The purpose of this study was
to explore trajectories of depressive symptoms from child-
hood to young adulthood between males and females and to
identify and compare critical points along these trajectories
for both populations.
This study’s results showed that females and males have
different population-averaged trajectories of depressive
symptoms, with varying ages of peak velocity of depressive
symptoms. Using multilevel growth-curve modelling on 8
waves of data between ages 11 to 22, results suggest that
females were on average associated with higher trajectories
of depressive symptoms compared to males, with the
exception of between 10 and 11 years old where on average
males had higher depressive symptoms. Both male and
female population-averaged trajectories increased during
adolescence before declining in young adulthood, yet
females on average had a higher rate of deceleration
(depressive symptoms slowing down) from age 20 and both
sexes had trajectories that ﬁrst plateaued and then started to
decline in young adulthood. Evidence suggested that that on
average, females had an earlier age of peak velocity of
depressive symptoms (i.e., age at which depressive symp-
toms is increasing most rapidly), but little evidence to
indicate that females had an earlier age of maximum
depressive symptoms (i.e., age at which depressive symp-
toms is highest on the trajectory). Finally, depressive
symptoms scores at the age of peak velocity and age of
maximum depressive symptoms were both higher for
females on average compared to males.
These ﬁndings support earlier hypothesis and previous
research that trajectories of depressive symptoms increase
from late childhood, through adolescence and begin to
decrease in young adulthood (Adkins et al. 2009; Ferro
et al. 2015b; Natsuaki et al. 2009). One possible explanation
for increased depressive symptoms during adolescence is
that young people face a number of social, psychological
and biological changes during this stage of development
Fig. 2 Averaged population trajectories for males and females. SMFQ
short mood and feelings questionnaire. Features of the trajectories are
overlaid with the following terms: ● Male age of peak velocity of
depressive symptoms. ▲ Male age of maximum depressive symp-
toms. ♦ Female age of peak velocity of depressive symptoms. ■
Female age of maximum depressive symptoms
Table 5 Calculated features from the trajectories of the cubic polynomial model
Males Females Difference p-value
Age of peak velocity in SMFQ 16.36 (0.1) 13.51 (0.32) 2.86 (0.34) <0.001
[16.18, 16.55] [12.88, 14.14] [2.2, 3.51]
Age of maximum SMFQ 20.42 (0.14) 19.61 (0.5) 0.80 (0.55) 0.14
[20.14, 20.69] [18.63, 20.6] [−0.27, 1.88]
SMFQ at peak velocity 4.76 (0.07) 5.42 (0.06) 0.66 (0.1) <0.001
[4.62, 4.91] [5.3, 5.55] [0.47, 0.85]
SMFQ at maximum point 5.75 (0.1) 7.7 (0.09) 1.95 (0.14) <0.001
[5.55, 5.95] [7.52, 7.88] [1.69, 2.22]
Standard errors are given in (parenthesis) 95% conﬁdence intervals are given in [parenthesis]
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(Adkins et al. 2009; Thapar et al. 2012). These changes
include transitioning between schools, making new friends,
taking exams and experiencing puberty. As many studies
highlight that trajectories of depressive symptoms increase
during this period, efforts should be made to monitor
individuals who show heighted depressive symptoms as
they may be individuals at a greatest risk of depression or
higher levels of depressive symptoms.
This study was also able to expand on previous work by
estimating points on population-averaged trajectories
marking the average age of peak velocity, of maximum
depressive symptoms and the depressive symptoms scores
at both of these ages. These results show the age of peak
velocity of depressive symptoms was almost 3 years earlier
for females. The results suggest that depressive symptoms
are increasing most rapidly for females at approximately
13.7 years old and for males at 16.4 years old, and that
treatment and interventions could be implemented at dif-
ferent ages for males and females. These ﬁndings have
implications for clinical services, schools and parents, who
should be made aware that females are more likely to be
younger when depressive symptoms are increasing most
rapidly, with males following at a later stage. Likewise, as
females appear to have higher trajectories for a longer of
period of time, more awareness could be targeted towards
services, schools and parents over this period of heightened
and increasing depressive symptoms. Identifying features
such as the age of peak velocity may help determine at what
age depressive symptoms are getting worse most rapidly,
but also highlight a key characteristic of trajectories of
depressive symptoms that is potentially modiﬁable. Future
research should primarily examine if the age of peak
velocity identiﬁed here is universal to other cultures and
countries and should also look to examine other predictors
of these ages to see if they are potentially modiﬁable. Given
that individuals with higher starting points (intercepts), had
steeper trajectories (slopes), it is important to identify
depressive symptoms early and when they are increasing as
the current results suggest that those who start with higher
depressive symptoms are at a greater risk of continuing to
have higher trajectories of depressive symptoms.
This study’s ﬁndings suggested that the age of maximum
depressive symptoms was approximately a year apart
between males (20.7 years old) and females (19.7 years
old), although evidence for a difference was weak. Several
studies have suggested that this age should occur around
mid-to-late adolescence, approximately between 15–17
years old (Ferro et al. 2015b; Natsuaki et al. 2009; Rawana
and Morgan 2014). However, other evidence has indicated
that this age of maximum depressive symptoms occurs later
in development (Ge et al. 2001; Sutin et al. 2013), which
coincides with the current results. There are several poten-
tial explanations as to why the current results observed a
much later age of maximum depressive symptoms com-
pared to some previous research. In several studies, the
number of depressive symptoms measurements from
follow-up are low and are therefore unable to pick up more
nuanced changes in depressive symptoms over time.
Depressive symptoms are dynamic and can change rapidly
over a short period, thus researchers need frequent mea-
surements to track subtle changes (Wesselhoeft et al. 2013).
In the present study, the measurements were assessed on
average never more than 3.5 years apart, which is more
regular than many of the previous studies. It could be that
frequently assessing depressive symptoms allowed detected
changes and characteristics of the trajectories that were not
observed in previous studies.
Another explanation is that variation in the age of
maximum depressive symptoms is the result of contextual
differences between the cohorts used. For example, similar
ages of maximum depressive symptoms were observed
using data from the National Longitudinal Study of Ado-
lescents Health (Costello et al. 2008; Natsuaki et al. 2009),
and the Canadian-based National Longitudinal Survey of
Children and Youth (Ferro et al. 2015b; Rawana and
Morgan 2014). However, other research using different
North American cohorts have observed later ages of max-
imum depressive symptoms (Ge et al. 2001; Sutin et al.
2013). ALSPAC is one of the few longitudinal studies in the
UK that currently has repeat depressive symptoms data
across this period of development so it hard to conclude
whether similar effects would be observed in other UK
studies at this point. Other studies that examine depressive
symptoms in longitudinal settings around the world use
alternative methods to derive latent classes of trajectories of
depressive symptoms (Costello et al. 2008; Yaroslavsky
et al. 2013), and as such it is harder to compare critical
points from these studies as there are often 4 or 5 trajec-
tories from each study (each with their own age of max-
imum depressive symptoms). However, an important point
to consider is that this study is the ﬁrst to empirically esti-
mate this age and present it with measures of uncertainty
rather than simply describing it from ﬁgures. It is unlikely
that this will explain the observed differences with other
studies, but in the interest of interpretability and to help
characterise the nature of trajectories of depressive symp-
toms, future research should estimate and report this age as
this will help clarify whether there cross cultural differences
for critical ages in the development of depression. Similarly,
this is the ﬁrst study to calculate and then compare critical
points from two population trajectories (males vs. females).
Interestingly, the current results supported previous research
that suggested no sex differences between the ages of
maximum depressive symptoms (Ge et al. 2001; Natsuaki
et al. 2009), but contradicted other research suggesting that
females have an earlier age of maximum depressive
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symptoms compared to males (Edwards et al. 2014).
However, the authors here did not use the same number of
measurements, used a quadratic polynomial model and only
had data that went up to approximately 18 years old. Future
research should examine depressive symptoms regularly
around these ages to see if the critical periods identiﬁed are
similar across contexts. Such research will inform services,
schools and parents about the nature of depression and how
to prevent and treat it around these ages.
Still, it is not clear why females on average have higher
trajectories of depressive symptoms and why females and
males differ in their ages of peak velocity of depressive
symptoms. One explanation is that women tend to experi-
ence puberty earlier than men and evidence has suggested
that early pubertal timing may be a mechanism responsible
for depression and higher depressive symptoms (Joinson
et al. 2012; Thapar et al. 2012). Research has also shown
that an earlier age of menarche is positively associated with
higher depressive symptoms (Joinson et al. 2013; Joinson
et al. 2011) and a causal mechanism for greater depressive
symptoms (Sequeira et al. 2017). Transitioning through
puberty is associated with other psychological and social
changes, and individuals who transition early may not have
developed the cognitive and emotional skills to combat these
changes, and therefore experience lasting effects of depres-
sive symptoms. Likewise, early pubertal changes could
result in increased responsiveness to stressors in females,
resulting in higher depressive symptoms (Thapar et al.
2012). These ﬁndings suggest that individuals with higher
starting points, had higher trajectories. Therefore an earlier
age of higher depressive symptoms may set an individual up
for a higher trajectory which takes longer to recover from.
This could explain why females have higher trajectories
compared to males, although more research using the timing
and changes in pubertal status for both males and females
would be needed to substantiate this claim.
Additionally, Angold et al. (1998) found that depression
was higher for females between the ages of 9 and 16, and
this seemed to coincide with both pubertal status and timing
of puberty. Of note, the number of girls with depression in
their study was highest at around age 14, which coincides
with the age of peak velocity of depressive symptoms in the
present study. This suggests there may be some common
mechanism at this age that is underpinning depressive
symptoms, and how this manifests. The age of peak velocity
from the current study tends to match the ages at which both
males and females experience puberty and so one possible
reason why the current study observed varying ages of peak
velocity of depressive symptoms between males and
females may be through the role of puberty.
Despite a number of strengths, this study has several
limitations that should be highlighted. One limitation that
arises with the data used here, and more generally with
longitudinal data, is attrition and the role this plays in biasing
results towards individuals who respond. The sample size in
this study decreased from 7,335 at the ﬁrst wave of data
collection to 3,840 by the eighth occasion opening the
possibility to potential attrition bias. Analysis on individuals
with depressive symptoms data at both the ﬁrst and last
occasion, compared to those with depressive symptoms data
at the ﬁrst occasion but not the last, revealed differences in
the overall symptoms scores and underlying demographics.
However, this is consistent with previous research (Edwards
et al. 2014), and suggests that studies with attrition could be
underestimating the effect of sex differences in trajectories
of depressive symptoms as females were more likely to have
not responded at the last occasion. Previous studies have
also imputed missing data utilising a missing at random
approach (MAR) but found that bias due to systematic
missingness in ALSPAC is not substantial (Bould et al.
2014; Pearson et al. 2017). The multilevel growth-curves
models used in the present study also use FIML to account
for missing data and sensitivity analyses revealed that the
main effects of this study (i.e., the trajectories and the critical
points) were not substantively affected by the inclusion of
covariates associated with missing data and attrition bias.
Nevertheless, future studies should highlight missing data
patterns and attempt to account for data that could poten-
tially be missing not at random.
Another limitation in this study stems from the choice of
model used and the assumptions made with multilevel
growth-curve models. Modelling trajectories of depressive
symptoms appropriately is challenging. A cubic polynomial
model was chosen given it is a more parsimonious approach
in comparison to splines and fractional polynomials and that
it has been used in previous studies that show nonlinearity
(Ferro et al. 2015a; Rawana and Morgan 2014). However,
alternative approaches such as a restricted cubic spline
model may ﬁt the data better at the expense of parsimony.
Similarly, a quartic polynomial model may be a better
model if the depressive symptoms data continues to rise.
Cubic terms (and other polynomials) may also perform
poorly at the start and end of the trajectories, as well as
potentially producing artiﬁcial turns in the data that do not
exist (Tilling et al. 2014). Checks were made to ensure that
no artiﬁcial turns occurred in the data by comparing against
other models and the underlying data and descriptive sta-
tistics for plausibility. Additionally, the age of peak velocity
of depressive symptoms and age of maximum depressive
symptoms were calculated well within the range of the
trajectories so any bias from potentially mismodelling the
start and end of the trajectories is minimised.
A similar limitation in this study is in regard to high-
lighting variability with the multilevel growth-curve model.
A problem with population growth curves like the ones
used in the present study is that it is harder to convey how
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much variability exists across the population, compared to
other methods such as latent class growth analysis or
growth mixture modelling, which typically stratify popula-
tion trajectories into multiple subpopulation trajectories.
Future research could derive critical periods from latent
class analysis to examine if certain groups of trajectories
have earlier ages of peak velocity or later times of max-
imum depressive symptoms. Such research could further
highlight variability in critical points across multiple
trajectories.
Conclusion
The nature of trajectories of depressive symptoms between
adolescence and young adulthood is not yet clear, but
research has suggested that increased levels of depressive
symptoms throughout this period are associated with a
greater risk of psychopathology and adverse social out-
comes in later life (Fergusson et al. 2007; Yaroslavsky et al.
2013). It is important to examine the nature of depressive
symptoms and identify critical periods that could potentially
be used to target a stage of development where depressive
symptoms are increasing at the fastest rate. A greater
understanding of these two facets would aid in developing
and improving treatments and interventions. This study
examined trajectories of depressive symptoms between
males and females in a large UK based population cohort
over multiple stages of development. Using multilevel
growth-curve models, the ﬁndings suggested that females
on average were associated with steeper trajectories of
depressive symptoms compared to males, indicating they
were more likely to experience higher depressive symptoms
for longer. Importantly, the age at which depressive
symptoms were increasing most rapidly were much earlier
for females on average compared to males. Whilst the
mechanisms underpinning this sex difference are not
entirely understood, pubertal status and the timing of pub-
ertal status could play a role in explaining why females on
average have higher trajectories and commence on these
trajectories earlier than males. Calculating the age of peak
velocity of depressive symptoms is a potentially useful tool
for exploring how depressive symptoms are changing and at
what age they are increasing most rapidly, which may have
consequences downstream. If this can be used for clinical
purposes, it may be possible to treat individuals at this age,
which may help reduce depressive symptoms or depression
at a later stage.
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